Redeye: Stable ground for growth in Imint

Imint has experienced an interesting Q2 with strong sales growth, two new agreements and continued growth of their organization. Imint has since then announced an additional license agreement with a Chinese manufacturer. We believe that Imint is well-positioned to experience future growth and reiterate our fair value of SEK 71 per share in base case. 

Read the Research Update by Dennis Berggren at:

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye – Research Powered Investment Banking.


We’re all about video enhancement

Book a Demo